Arcus Biosciences, Inc. (RCUS)

SEC filing

Arcus Biosciences, Inc.

RCUS · CIK 1724521

4 · Aug 24, 2026 · Chief Accounting Officer Azoy Alexander sold 2,827 shares at $30.00/share ($84,810); exercised options for 5,654 shares

Chief Accounting Officer Azoy Alexander sold 2,827 shares at $30.00/share ($84,810); exercised options for 5,654 shares

FORM 4

xslF345X06/wk-form4_1787608336.xmlSEC.gov

Graphics and non-inline formats (not embedded below).